Table 1: Patients with ovarian carcinoma, extra-ovarian peritoneal carcinoma and fallopian tube carcinoma with BRCA1/2 study.

Patient	Primary tumor	Tumor BRCA 1/2	GCU visit	Germline BRCA 1/2
1	Ovarian	NPV	No	NS
2	Ovarian	NPV	Yes	NPV
3	Ovarian	NPV	Yes	NPV
4	Synchronous ovarian and endometrial cancer	NPV	No	NS
5	Ovarian	NPV	Yes	NPV
6	Ovarian	NPV	Yes	NPV
7	Ovarian	BRCA1 mutation	Yes	Normal
8	Ovarian	BRCA1 mutation	Yes	BRCA1 mutation
9	Ovarian	NPV	Yes	NPV
10	Ovarian	NPV	Yes	NS
11	Ovarian	NPV	No	NS
12	Ovarian	BRCA1 mutation	Yes	Normal
13	Ovarian	NPV	No	NS
14	Ovarian	BRCA1 mutation	Yes	BRCA1 mutation
15	Ovarian	BRCA2 mutation	Yes	BRCA2 mutation
16	Ovarian	NPV	Yes	NS
17	Ovarian	NPV	Yes	NS
18	Ovarian	BRCA1 mutation	Yes	BRCA1 mutation
19	Ovarian	NPV	Yes	NPV
20	Ovarian	NPV	No	NS
21	Ovarian	NPV	Yes	NPV
22	Ovarian	Insufficient sample	Yes	NPV
23	Ovarian	NPV	Yes	NS
24	Ovarian	NPV	Yes	NPV
25	Peritoneal extraovarian carcinoma	NPV	No	NS
26	Ovarian	NPV (BRCA2 VUS)	Yes	NPV
27	Ovarian	NPV	Yes	NPV
28	Ovarian	NPV	Yes	NS
29	Ovarian	Insufficient sample	Yes	BRCA1 mutation
30	Ovarian	NPV	No	NS
31	Peritoneal extraovarian carcinoma	NPV	Yes	NPV
32	Ovarian/peritoneal extraovarian carcinoma	NPV	No	NS
33	Ovarian	NPV	No	NS
34	Ovarian	NPV	Yes	NPV
35	Ovarian	NPV	Yes	NPV (BRCA1 VUS)
36	Ovarian	NPV	Yes	NPV
37	Ovarian	Insufficient sample	Yes	BRCA2 mutation
38	Ovarian	BRCA1 mutation	Yes	Normal
39	Ovarian	BRCA1 mutation	Yes	BRCA1 mutation
40	Ovarian	BRCA1 mutation	Yes	BRCA1 mutation
41	Ovarian	Insufficient sample	No	NS
42	Fallopian tube	BRCA2 mutation	Yes	BRCA2 mutation
43	Ovarian	NPV	No	NS

NPV: no pathogenic variants (when both genes are studied); Normal: no mutation (when only the pathogenic variant uncovered at the tumor is studied); NS: not studied; VUS: variant of unknown significance.